RWGI - 4/20 Cannabis Stocks: Key Players in the Growing Market

(NewsDirect)

For those seeking apromising investment opportunity in the cannabis market, RodedawgInternational Industries, Inc. (OTC: RWGI) 's progress on its2024 roadmap is a compelling proposition. The company's strategicapproach, coupled with regular updates on its growth and milestones,points to the potential for expansion in the emerging cannabisindustry.

As 4/20approaches, it's a perfect time to check in on cannabis stocks.After years of stagnation, the sector is experiencing a resurgence,thanks to several encouraging factors that have pushed it higher inrecent weeks.

Forstarters, the growing support for legalization among Americans—nowat about 88%, according to Pew Research—could make cannabis a keytopic in the upcoming U.S. elections. Candidates who supportlegalization may see a boost in their ratings, which could drive themarket even further.

Florida is one state that may soon legalize adult-use cannabis.The Florida Supreme Court has proposed Amendment 3, which, ifapproved, could take effect in May 2025. There's also speculationabout potential cannabis rescheduling by the DEA before the Novemberelection, which could further impact the sector.

With all these factorsat play, cannabis stocks could see even higher highs. Let's take alook at four potential players in the sector!

Curaleaf Holdings,Inc. (OTCQX: CURLF) is a leading international cannabis provider,offering quality and reliability in the industry. Known for its brandsCuraleaf, Select, and Grassroots, the company serves both medical andadult-use markets. In the U.S., it operates in 17 states with 145dispensaries and employs over 5,600 people worldwide. CuraleafInternational is the largest vertically integrated cannabis company inEurope, combining pioneering research with advanced cultivation andproduction.

In thefourth quarter of 2023, Curaleaf reported record revenue of $345.3million, a 4% increase from the previous quarter. Adjusted grossmargin was 46%, with adjusted EBITDA of $83 million, representing 24%of sales. Full-year revenue reached $1.35 billion, up 6% from 2022.Despite facing a net loss of $281.2 million for the year,Curaleaf's gross profit and EBITDA margins show strong potentialfor growth.

Operational highlights include significant expansions in stateslike Florida and New York and an uplisting to the Toronto StockExchange in December 2023. Curaleaf also launched new products such asBriq vapes and Zero Proof drinkables.

In major news, Curaleaf announced the acquisitionof Northern Green Canada, a Canadian cannabis producer with EU-GMPcertification. This deal solidifies Curaleaf's position in theEuropean market and expands its presence in North America, Europe, andAustralasia. The acquisition will provide high-quality, indoor-growncannabis to meet growing demand, particularly in Germany.

Curaleaf's recentachievements and strategic expansions demonstrate its commitment toenhancing its global presence and solidifying its role as a key playerin the cannabis industry. The company will report its Q1 2024 resultson May 9, 2024.

Cresco Labs, Inc. (OTCQX: CRLBF) is a leading cannabiscompany with a strong focus on building national brands and providinga consumer-centered retail experience. The company operates under theSunnyside dispensary brand and is known for its commitment to quality,safety, and community engagement.

Cresco Labs has a portfolio of brands such asCresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindys,and Remedi. These brands offer a variety of products, includingflowers, vapes, concentrates, topicals, edibles, and tinctures.

The company recentlyannounced the promotion of Greg Butler to president, recognizing hiscontributions to Cresco Labs and his ability to lead the company intothe future. Butler will oversee all aspects of the company'soperations, including production, retail, marketing, sales, corporateplanning, and investor relations.

Cresco Labs' strategic focus on core marketshas led to continued growth, as evidenced by the opening of newSunnyside dispensaries, including a recent one in Gettysburg,Pennsylvania. The company holds the number one market share positionin Illinois, Pennsylvania, and Massachusetts.

Cresco Labs'financial performance demonstrates its progress and efficiency in thecannabis industry. In the fourth quarter of 2023, the company reportedrevenue of $188 million, adjusted gross profit of $100 million, andadjusted EBITDA of $55 million. For the full year of 2023, Cresco Labsreported revenue of $771 million and adjusted EBITDA of $174million.

Thecompany's focus on cost management, margin expansion, andprofitability has resulted in significant improvements in itsfinancials. Cresco Labs continues to prioritize its core strategywhile positioning itself for future growth opportunities in thecannabis industry.

Investors looking for growing companies in the cannabis segmentmay find Cresco Labs to be an attractive option, given its strongmarket position, robust portfolio, and dedication to responsibleindustry practices.

BYND Cannasoft Enterprises Inc. (NNASDAQ: BCAN) is anIsraeli-based integrated software and cannabis company focused on thewomen's health and wellness market. Leveraging its experience incustomer relationship management (CRM) software, BYND Cannasoft isdeveloping innovative platforms for the medical cannabis industry andwellness technologies tailored for women's health.

The company reported achallenging financial year ending December 31, 2023, with revenue down4% year-over-year to $1,076,861 and a drastic increase in net loss to$18,495,121, primarily due to impairments. BYND Cannasoft facessignificant hurdles as it navigates changes in its core activities inIsrael, in addition to the difficult war in Gaza, which affectedoperations.

Toaddress these challenges, BYND Cannasoft announced the pricing of a $7million underwritten public offering in March 2024 and a 1-for-190reverse stock split. These actions aimed to consolidate the sharestructure and raise funds for further development.

The company's focuson the Fem-Tech market presents an opportunity in a sector expected togrow to $139.51 billion by 2031. BYND Cannasoft is using its SmartDelivery System (SDS) to create innovative products for women'ssports, hair, and cosmetics sectors. These include smart cosmetic facedevices, hair growth brushes, and muscle pain relief regulators.

The company also plansto capitalize on the growing CBD market, expected to reach $36 billionwithin a decade. In partnership with Foria, BYND Cannasoft aims tooffer CBD-based products for personal care and wellness.

While the company haspotential in emerging markets, it faces challenges such as stiffcompetition and regulatory hurdles. Its success will hinge on itsability to navigate these obstacles and achieve sustainedprofitability. Investors should closely watch BYND Cannasoft'sprogress in product development and market penetration for long-termpotential.

Rodedawg International Industries, Inc. (OTC: RWGI) is acompany focused on the regulated California cannabis market, engagingin various sectors such as cultivation, distribution, manufacturing,and retail dispensaries. Through its wholly owned subsidiary, ParabolaMgmt. LLC, Rodedawg has expanded its operations and strategicallyacquired licenses to solidify its market presence.

In January 2024, RWGI made significant strides toward growth by acquiring a newCalifornia cannabis distributor license in Coachella, California. Thisachievement aligns with the company's roadmap and first-quartermilestones, showcasing RWGI's commitment to rapidly growing itscannabis license portfolio. This strategic move aims to increase thecompany's revenue streams and pave the way toward its ambitiousgoal of $7 million in annual revenue.

RWGI has also accelerated sales of hemp andcannabis-derived isolates. In the previous quarter, the companyinvested over six figures in a manufacturing facility for theextraction of cannabis-derived isolates from hemp. This significantinvestment has enabled RWGI to reach 65% production capacity,contributing to rapid revenue growth and establishing the company as aleader in the global cannabis market.

The company's latest updates from April 16,2024, highlight RWGI 's diverse enterprise, which includesthe following areas of focus:

CostaMesa License: The company operates under a Costa Mesa license formanufacturing, distribution, and off-site delivery.

• Coachella Facility: RWGI procures hemp-derived isolatesboth for itself and as a service for other producers.

• Proprietary Brands: RWGI ownsproprietary cannabis retail brands, such as Brother Buds and TreeMoguls.

• Elixicure: RWGI produces a proprietary and trademarked topical pain reliefroll-on and spray.

Furthermore, RWGI has initiated thecancellation of over 100 million outstanding shares, which couldenhance shareholder value and reflect the company's focus onrevenue growth. This decision complements the consistent progress thecompany has shown in its operations and revenue generation.

RWGI 'sfinancial statements reveal a remarkable increase in revenues, whichrose from $30,000 in December 2022 to $103,868 in December 2023. Thissubstantial growth indicates operational efficacy and a strong upwardtrajectory, which is crucial for potential investors.

For those seeking a promising investmentopportunity in the cannabis market, Rodedawg InternationalIndustries, Inc.'s (OTC: RWGI) progress on its 2024 roadmap isa compelling proposition. The company's strategic approach,coupled with regular updates on its growth and milestones, points tothe potential for expansion in the emerging cannabis industry.

Disclaimers:CapitalGainsReport (CGR) is not operated by alicensed broker, a dealer, or a registered investment adviser. Thiscontent is for informational purposes only and is not intended to beinvestment advice. The Private Securities Litigation Reform Act of1995 provides investors a safe harbor in regard to forward-lookingstatements. Any statements that express or involve discussions withrespect to predictions, expectations, beliefs, plans, projections,objectives, goals, assumptions, or future events or performance arenot statements of historical fact may be forward looking statements.Forward looking statements are based on expectations, estimates, andprojections at the time the statements are made that involve a numberof risks and uncertainties which could cause actual results or eventsto differ materially from those presently anticipated. Forward lookingstatements in this action may be identified through use of words suchas projects, foresee, expects, will, anticipates, estimates, believes,understands, or that by statements indicating certain actions &quote; may, could, or might occur. Understand there is no guaranteepast performance will be indicative of future results. Investing inmicro-cap and growth securities is highly speculative and carries anextremely high degree of risk. It is possible that an investorsinvestment may be lost or impaired due to the speculative nature ofthe companies profiled. CapitalGainsReport (CGR) has been retained byAwareness Consulting to assist in the production and distribution ofcontent related to JEWL. 'CGR' is responsible for theproduction and distribution of this content. It should be expresslyunderstood that under no circumstances does any information publishedherein represent a recommendation to buy or sell a security. Thiscontent is for informational purposes only, you should not construeany such information or other material as legal, tax, investment,financial, or other advice. Nothing contained in this articleconstitutes a solicitation, recommendation, endorsement, or offer byCapitalGainsReport or any third party service provider to buy or sellany securities or other financial instruments. All content in thisarticle is information of a general nature and does not address thecircumstances of any particular individual or entity. Nothing in thisarticle constitutes professional and/or financial advice, nor does anyinformation in the article constitute a comprehensive or completestatement of the matters discussed or the law relating thereto. CGR isnot a fiduciary by virtue of any persons use of or access to thiscontent.

ContactDetails

CapitalGainsReport

MarkMcKelvie

+1 585-301-7700

Markrmckelvie@gmail.com

CompanyWebsite

http://razorpitch.com

Copyright (c) 2024 TheNewswire - All rights reserved.